Program structure
Tuesday
April 22
Wednesday
April 23
Thursday
April 24
Friday
April 25
Saturday
April 26
Day of arrival
16.00-19.00
Registration
19.00 Welcome
19.15 Keynote
Lecture
20.00 Welcome Dinner
08.30-12.00
Session 1;
Plasma Proteomics
Lunch
13.00-16.00 Walking tour of Willemstad
17.00-17.30
Focus Lecture 1
17.30-20.30
Session 2; Pathogen and Prion Safety
08.30-12.00
Session 3; Development and New Technologies
Buffet lunch
Free time
16.00-17.00 Poster Session; Authors to be available
17.00-17.30
Focus Lecture 2 17.30-20.30
Session 4; Regulatory Perspectives
08.30-12.00
Session 5; Clinical Issues in Plasma Products
Buffet lunch
Free time
15.00-18.30
Session 6;
Manufacturing Perspectives
19.30 -
Caribbean Night Dinner
Day of departure
|
Tuesday April 22 |
Wednesday April 23 |
Thursday April 24 |
Friday April 25 |
Saturday April 26 |
|
Day of arrival
16.00-19.00 19.00 Welcome |
08.30-12.00
|
08.30-12.00
16.00-17.00 Poster Session; Authors to be available |
08.30-12.00 Buffet lunch 15.00-18.30 19.30 - |
Day of departure |
Plasma Protein Products, Opportunities for the Future
Jan Over, Sanguine Blood Supply Foundation, The Netherlands
Safety of blood and blood components for transfusion in Latin America and the Caribbean.
Jose Ramiro Cruz, Pan American Health Organization, USA
Plasma Fractionation in China and SouthEast Asia
Neil Goss, Further Options Pty Ltd.
| Session | Chairing | Affiliation |
| Plasma Proteomics | David Hammond | American Red Cross, USA |
| Pathogen and Prion Safety | Bernard Horowitz |
Bernard Horowitz Consulting, New York, USA |
| Development and New Technologies | Christopher Bryant | Aventis Behring, USA |
| Regulatory Perspectives | Mary Ann Lamb | Bayer, N.C., USA |
| Clinical Issues in Plasma Products | Peter Späth | ZLB Bioplasma AG, Bern, Switzerland |
| Manufacturing Perspectives | Johan Vandersande | Baxter, Los Angeles, USA |